Inhibition of erythromycin lactobionate-induced writhing by analgesic drugs.
D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D003061:Codeine / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000627:therapeutic use; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009020:Morphine / Q000627:therapeutic use; D009269:Nalorphine / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy*; D010653:Phenylbutazone / Q000627:therapeutic use
D000700:Analgesics; C010948:erythromycin lactobionate; D009270:Naloxone; D004917:Erythromycin; D009020:Morphine; D010653:Phenylbutazone; D001241:Aspirin; D011431:Dextropropoxyphene; D009269:Nalorphine; D003061:Codeine; D007213:Indomethacin